Literature DB >> 6544190

Prelytic reduction of high-energy phosphates induced by antibody and complement in nucleated cells. 31P-NMR study.

R Tirosh, H Degani, G Berke.   

Abstract

Using 31P-NMR spectroscopy, we have investigated possible involvement of metabolic processes in the lysis of nucleated cells induced by low levels of antibody to cell surface antigens and complement. Within 10 min of antibody plus complement attack, before onset of overt lysis, we have observed a marked, selective reduction in the intracellular content of phosphocreatine and adenosine triphosphate (ATP). A longer attack is accompanied by total depletion of either phosphocreatine or ATP in residual cells which preserved other phosphate compounds. The results indicate that in nucleated cells formation of putative complement-dependent membrane channels induces exhaustive hydrolysis of ATP. It is suggested that ATP deprivation could in turn lead to colloid-osmotic swelling, membrane rupture, and cell death.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6544190     DOI: 10.1159/000467839

Source DB:  PubMed          Journal:  Complement        ISSN: 0253-5076


  4 in total

1.  Non-lethal complement-membrane attack on human neutrophils: transient cell swelling and metabolic depletion.

Authors:  B P Morgan
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

Review 2.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

3.  Thyroid follicular cell function after non-lethal complement membrane attack.

Authors:  A P Weetman; M Freeman; B P Morgan
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 4.  Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.

Authors:  Zvi Fishelson; Michael Kirschfink
Journal:  Front Immunol       Date:  2019-04-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.